Assessment of Cortical Myelination in Patients with MS via T1-Weighted/FLAIR Ratio: A Longitudinal Follow-up Study

Junsung Kim1,2, Da-Young Seo3, Eunseon Jeong1

  • 1From the Department of Radiology and Research Institute of Radiology (J.K., E.J., Y.C.), University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.

Abstract

Insights

The T1-weighted (T1W)/FLAIR ratio in gray matter may track disease severity in patients with multiple sclerosis (MS). Longitudinal changes in this ratio correlate with disability progression, suggesting its use as a biomarker.

Area of Science:

  • Neuroimaging
  • Neurology
  • Biomarker Discovery

Background:

  • Cortical demyelination is a key feature of multiple sclerosis (MS).
  • The T1-weighted (T1W)/FLAIR ratio may serve as an indicator of cortical myelin integrity.
  • Longitudinal assessment of this ratio's significance in MS is crucial.

Purpose of the Study:

  • To investigate the longitudinal significance of the cortical T1W/FLAIR ratio in patients with MS (PwMS).
  • To explore the relationship between T1W/FLAIR ratio changes and clinical parameters in PwMS.

Main Methods:

  • Acquired brain MRI data (3D T1W and FLAIR) from PwMS and patients with clinically isolated syndrome (CIS).
  • Calculated gray matter (GM) and superficial white matter (WM) T1W/FLAIR ratios.
  • Analyzed longitudinal changes and correlations with Expanded Disability Status Scale (EDSS) and disease duration.

Main Results:

  • GM T1W/FLAIR ratio changes negatively correlated with EDSS changes in superficial GM (r = -0.201, P = .02) and occipital cortex (r = -0.269, P = .002).
  • Increased GM T1W/FLAIR ratios were observed in patients with stable or improved EDSS scores.
  • T1W/FLAIR ratio changes positively correlated with disease duration (r = 0.285, P = .02) but not WM lesion changes.

Conclusions:

  • Longitudinal GM T1W/FLAIR ratio changes are associated with disease severity in PwMS.
  • The cortical T1W/FLAIR ratio shows potential as a biomarker for cortical myelination and disease monitoring in MS.